NHS Health Checks now include AUDIT-C, a brief screening tool designed to help identify people who may be problem drinkers. Taking the test can be a sobering experience for patients, but now is the time to get a grip on our national relationship with alcohol.
Ask, ask, ask…about alcohol
Back to Basics: Alcohol use disorders identification test (Audit-C)
Back to Basics: High-risk drinking and the liver
Back to Basics: The effects of high risk drinking on the body
Alcohol and the heart: food, medicine or poison?
People have been producing alcohol for thousands of years and consuming it as part of their diet as well as for medicinal purposes. When taken in moderation, drinking alcohol can be a safe and pleasurable activity with potential heart health benefits. However, those cardiovascular benefits are lost when alcohol is consumed in excess, and drinking becomes harmful with adverse physical, psychological and social consequences.
Alcohol and sex: a risky mixture for sexual health
Alcohol-related harm is a major public health concern, and since April 2013 questions to identify problem drinkers have been included in the NHS Health Check for people aged 40-74 years. But young people are also a key at-risk group for hazardous consumption, and the physical harms of alcohol may be compounded by risks to their sexual health.
Over the limit? A healthier approach to alcohol
Alcohol forms part of the diet for over 90% of adults in the UK and is unusual in being both a nutrient and a drug. For many of us, alcohol is a safe and pleasurable part of the diet. However, there is growing concern that many people who see themselves as social drinkers are consuming levels that may cause harm. Understanding how to assess safe levels of alcohol consumption and identify strategies for cutting down can help us to advise our patients how to moderate their intake.
The importance of early diagnosis: how to identify patients with FH for diagnosis and referral
Familial hypercholesterolaemia (FH) is under-diagnosed and under-treated, despite clear evidence-based guidelines for identification and management, and the availability of low-cost, generic, high-intensity statin treatment. Genetic cascade testing is the key to early diagnosis, which can help ensure that this treatment is no longer ‘too little, too late’.
HEART UK – The Cholesterol Charity – has provided editorial support and review of this sponsored FH series.This article was made possible by an unrestricted educational grant by Sanofi, who had no control over content.
The ESH/ESC guidelines for the management of arterial hypertension
There still remains a significant gap between the goal of optimal treatment of hypertension and ‘real life’ practice. As a consequence, hypertension remains a leading cause of cardiovascular related morbidity and mortality. There is a continuing need to improve both the detection and management of hypertension, with a view to improving the efficacy of treatment including lifestyle interventions and outcomes. In order to address these issues. The European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) have recently published guidance on the management of arterial hypertension.
Hypertension: an evidence update
Since the publication of the National Institute for Health and Clinical Excellence (NICE) clinical guidance (CG 127) on the management of hypertension in adults two years ago, new evidence has been published which is relevant to – and potentially has an impact on – the guideline recommendations. This evidence is presented and reviewed in the following article.
Regional variation in treatment: the London effect
This study shows that people living in London have better treatment rates with lipid lowering drugs than the general population. This observation may be explained in part by the fact that London is a highly mobile population, so new patient checks are more common.
